Vaccines Financial News

06.09 / 17:37
country outbreak reports prevention infection donates Vaccines WHO and Africa CDC launch a response plan to the mpox outbreak
The Africa Center for Disease Control and Prevention and the World Health Organization have launched a continent-wide response plan to the outbreak of mpox
01.09 / 14:27
Death Virus hospital prevention infection symptoms Vaccines EEE Virus: Why the US is worried about this deadly mosquito-borne disease. Here are the causes, symptoms & treatment
mosquito-borne disease caused by the Triple E virus, also known as the eastern equine encephalitis (EEE) virus. Recently, a US resident died after being hospitalized with eastern equine encephalitis, with cases also detected in other states. This year marked the first recorded death due to the virus, involving a 41-year-old individual from New Hampshire. But what is eastern equine encephalitis? How is it spread? What role do horses play? And is it a concern for Australia?
01.09 / 08:56
Fighting hospital outbreak prevention symptoms Vaccines Health authorities begin large-scale polio vaccinations in war-ravaged Gaza
health authorities and United Nations agencies on Sunday began a large-scale campaign of vaccinations against polio in the Gaza Strip, hoping to prevent an outbreak in the territory that has been ravaged by the ongoing Israel-Hamas war. Authorities plan to vaccinate children in central Gaza until Wednesday before moving on to the more devastated northern and southern parts of the strip. The campaign began with a small number of vaccinations on Saturday and aims to reach about 640,000 children. Israel has agreed to limited pauses in fighting to facilitate the campaign, according to the World Health Organization.
30.08 / 20:42
Pfizer Food Novavax strain Updates Vaccines US clears updated COVID shots from Novavax, adding a 3rd fall vaccine option
U.S. regulators have cleared a third updated COVID-19 vaccine for this fall, shots made by Novavax Inc. The Food and Drug Administration cleared updated shots made by Novavax on Friday
29.08 / 18:06
Continental community country outbreak patient strain Vaccines The Mpox crisis is much bigger than Mpox
mpox infection. Fear and stigma make it difficult for patients to seek medical attention soon after symptoms arise, which include a painful rash, fever, muscle aches and sore throat. Misinformation is spreading rapidly.
27.08 / 17:59
Target Death Immunic Research patient Vaccines 1st lung cancer vaccine trials launch, powered by COVID mRNA technology
The mRNA revolution continues. Just a few years after mRNA vaccines proved their efficacy against COVID-19, scientists are now turning their attention to lung cancer.
27.08 / 16:40
community Virus outbreak 2020 reports infection Vaccines park Dangerous mosquito virus spurs dusk-to-dawn park closures in U.S. town
Due to an increasing threat from a potentially deadly mosquito-borne disease, a coastal town in Massachusetts has closed its parks, playgrounds and sports fields from dusk to dawn, according to town officials.
20.08 / 18:06
Man Election President Photos country Vaccines Central agencies did not come calling when Bal Thackeray criticised Rajiv: Uddhav Thackeray at Congress event
Shiv Sena (UBT) chief Uddhav Thackeray on Tuesday said that despite being bitter rivals in the past, the undivided Shiv Sena and Congress were never vindictive towards each other. Speaking at a 'Sadbhavana Diwas' event here to mark the birth anniversary of the late Rajiv Gandhi, Thackeray also noted that Central agencies never harassed Shiv Sena leaders even though party founder Bal Thackeray had criticised the then prime minister in his speeches. Thackeray, who joined hands with the Congress in 2019 after parting ways with the Bharatiya Janata Party, took part in a Congress event for the first time. He also wore a Congress scarf for a brief time. The programme was also attended by NCP (SP) chief Sharad Pawar and Congress president Mallikarjun Kharge.
17.08 / 07:29
Death country outbreak reports medicines infection Vaccines Explained: Why mpox is sparking global concern again
Africa but now reported outside the continent. While Mpox spreads more slowly than the novel coronavirus, it can still be lethal, depending on the strain. Cases detected in Sweden, Pakistan Sweden said a person who had got back from Africa has tested positive for mpox. The case was identified a day after World Health Organization (WHO) declared the latest outbreak of the disease as a public health emergency of international concern and warned that Europe could see more imported cases. On Friday, Pakistan became the second country outside Africa to report a positive case. The patient had returned from a Gulf country. Pakistani health authorities said tests were underway to determine the variant involved.
16.08 / 11:40
Research outbreak reports infection strain International Vaccines ICMR conducting serosurvey to assess mpox risk in India
WHO declares Mpox a global public health emergency; ‘coordinated international response essential,’ says DG Tedros Mpox is a self-limiting viral zoonotic infection (spreading between animals and humans) with symptoms like smallpox, but with less clinical severity. It causes painful skin lesions, fever, headaches and muscle aches. Human-to-human transmission occurs mainly through large respiratory droplets requiring prolonged close contact.
15.08 / 17:54
Death Virus country outbreak reports prevention Vaccines Mpox outbreaks: What you need to know about the global health emergency
Africa Centers for Disease Control and Prevention declared mpox a public health emergency on the continent. WHO reported more than 14,000 cases and 524 deaths in Africa this year, which exceeds last year's figures. Over 96% of these cases are concentrated in Congo, where a new, possibly more transmissible form of the virus is causing concern.
15.08 / 17:27
markets UPS Manufacturing country International Vaccines Mpox vaccine maker ready to produce 10 million doses
Bavarian Nordic said Thursday it was ready to produce up to 10 million doses of its vaccine targeting mpox by 2025 after the World Health Organization declared a surge in the virus in Africa a global public health emergency. Alarmed by a rise in cases in the Democratic Republic of Congo and the spread of mpox to nearby countries, WHO experts said Wednesday that the «situation constitutes a public health emergency of international concern». «We have additional manufacturing capacity of two million doses for 2024 and (a total of) 10 million doses by 2025,» Rolf Sass Sorensen, vice-president of Bavarian Nordic, told AFP.
15.08 / 09:41
Fighting WhatsApp Research wellness show medicines Vaccines In a medical breakthrough, first phase-3 dengue vaccine trial begins in India
DengiAll is developed by the Indian pharma company Panacea Biotec and has shown good results in initial trials. Panacea Biotec is working with the Indian Council of Medical Research (ICMR), India’s top health research body, to conduct this trial. The goal is to see how well DengiAll works compared to the current standard treatments. The trial will involve 10,335 healthy adults and will be conducted at 19 locations across 18 states and Union territories. The ICMR is funding the trial.
13.08 / 17:30
CEO Pfizer Seagen Vaccines Pharmaceuticals Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatments
Pfizer's CEO Albert Bourla is trying to reposition the global pharmaceutical giant for a post-pandemic world
03.08 / 15:18
Target Immunic wellness Virus infection Vaccines Your ‘summer cold’ could likely be COVID-19, doctors say amid surge
COVID-19.“I thought, ‘Really? It’s summer,'” the marketing and communications professional said in an interview from St. Catharines, Ont.About a week later while camping, Robin woke up with a sore throat and felt achy later in the day.
31.07 / 16:33
markets Platform Healthcare Trade reports Vaccines Pharmaceuticals Mankind Pharma net profit jumps 10% to Rs 543 crore inQ4 to Q1
Mankind Pharma on Wednesday reported a 10% year-on-year (YoY) jump in net profit to Rs 543 crore in Q1FY25 led by strong domestic formulation sales. The drug maker reported net profit of Rs 494 crore in the corresponding period of previous year.
27.07 / 12:08
markets wellness Healthcare innovations patient Vaccines Dr. Reddy's Lab Q1 Results: Profit down 1% to Rs 1,392 crore but revenue jumps 14%
pharma major Dr. Reddy's Laboratories on Saturday announced that its June quarter profit after tax fell 0.8% year-on-year (YoY) to Rs 1,392 crore while revenue jumped 13.9% to Rs 7,673 crore. While announcing the quarterly numbers, the company's board also approved split of equity shares in the ratio of 1:5, which means that 1 existing share will split into 5.
25.07 / 09:33
markets UPS Manufacturing wellness reports medicines Vaccines trumps Mankind Pharma trumps EQT-ADIA, set to acquire BSV for Rs 14,000 crore
Mankind Pharma, India’s fourth largest pharma company by market share, is all set to acquire BSV Group, formerly Bharat Serum & Vaccines, from Advent International for around Rs 14,000 crore ($1.67 billion), people aware of the development told ET. Mankind will be trumping a rival bid from a consortium of EQT and Abu Dhabi Investment Authority (ADIA).
24.07 / 13:29
markets economy wellness pandemic Vaccines Here's why you may get a smaller pay raise next year
Many workers will see their annual raise shrink next year as the job market continues to cool from its torrid pace in the pandemic era.
23.07 / 04:51
markets UPS Provident Man wellness Vaccines Budget 2024 key announcements for common man: Will aam aadmi get the much-needed relief from inflation?
Nirmala Sitharaman is set to present her 7th straight Union Budget today, surpassing the record of former Prime Minister Morarji Desai. This is also the first full Budget of the Modi 3.0 government. With the BJP coming to power for the third time, albeit with fewer seats, there were high expectations from the Budget. Many expected Sitharaman to provide much-needed relief to the salaried, middle class, and the common man.

popular questions about Vaccines

What is Vaccines and why is it important?

Vaccines is a trending topic that interests a wide audience. On our site, we regularly publish updates related to this subject.

Where can I find the latest updates on Vaccines?

All recent news about Vaccines can be found in the dedicated section. We publish information as it becomes available.

How can I verify the accuracy of information on Vaccines?

We rely on trusted sources to ensure that the information about Vaccines is accurate and valuable for our readers.